Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Randomized, Double-blind Ketamine Augmentation in Chronically Suicidal, Treatment-resistant Major Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01667926

Organisation Name: Massachusetts General Hospital

Overal Status: Completed

Start Date: January 2013

Last Update: April 20, 2017

Lead Sponsor: Massachusetts General Hospital

Brief Summary: Ketamine infusions resulted in an acute reduction in global depression scores and in severity of suicidal ideation. The investigators therefore plan to investigate the feasibility and efficacy of repeated intravenous administration of ketamine in severely depressed, treatment resistant patients. The results of the study could lead to development of new strategies for treating depression.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.16478896141052